Abivax (ABVX) announced the trading resumption of its ordinary shares on the regulated market of Euronext Paris as from 3:30 p.m. CEST. Trading of the ordinary shares of the Company was halted at the request of the Company on July 24, 2025 from 9:00 a.m. CEST in the context of the previously announced public offering by the Company of its American Depositary Shares, each representing one ordinary share, EUR 0.01 nominal value per share, of the Company, in the United States, in order to allow for the confirmation of allocations to investors and the announcement of the pricing of the Offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABVX:
- Why Is Abivax Stock (ABVX) Up 490% Today?
- Abivax $400M Spot Secondary; price range $62.50-$65.00
- Abivax announces $400M ADS offering
- Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
- Trump announces tariff deal with Japan, AT&T reports Q2 beat: Morning Buzz